- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 217/18 - Aralkyl radicals
Patent holdings for IPC class C07D 217/18
Total number of patents in this class: 65
10-year publication summary
|
4
|
1
|
4
|
8
|
1
|
2
|
4
|
4
|
1
|
6
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Actelion Pharmaceuticals Ltd | 530 |
4 |
| Cytosinlab Therapeutics Co., Ltd. | 15 |
4 |
| Intervet Inc. | 911 |
3 |
| The Scripps Research Institute | 1346 |
3 |
| Novartis AG | 10744 |
2 |
| The Board of Trustees of the Leland Stanford Junior University | 6428 |
2 |
| China State Institute of Pharmaceutical Industry | 21 |
2 |
| Shanghai Institute of Pharmaceutical Industry | 129 |
2 |
| Taisho Pharmaceutical Co., Ltd. | 875 |
2 |
| Zentiva k.s. | 574 |
2 |
| SpecGx LLC | 188 |
2 |
| Huaqiao University | 79 |
2 |
| Idorsia Pharmaceuticals Ltd. | 352 |
2 |
| Jubilant Epicore LLC | 5 |
2 |
| Shanghai Zhimeng Biopharma Inc. | 33 |
2 |
| Bayecao Health Industry Research Institute (Xiamen) Co., Ltd. | 2 |
2 |
| Bristol-myers Squibb Company | 4880 |
1 |
| Samsung Display Co., Ltd. | 34907 |
1 |
| BASF SE | 20940 |
1 |
| Boehringer Ingelheim International GmbH | 4642 |
1 |
| Other owners | 23 |